These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9475257

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of beta-adrenoceptor blockade on beta-adrenergic signal transduction in cardiomyopathic hamster (BIO 8262) hearts.
    Witte K, Kinzler N, Schnecko A, Olbrich HG, Lemmer B.
    Eur J Pharmacol; 1997 Sep 10; 334(2-3):209-16. PubMed ID: 9369350
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.
    Wolf PS, Pruss TP, Rand MJ, Smith RD, Mann WS, Romano DV.
    J Hypertens Suppl; 1985 Dec 10; 3(3):S195-7. PubMed ID: 2908816
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prolongation of the life span of cardiomyopathic hamster by the adrenergic beta 1-selective partial agonist denopamine.
    Kurosawa H, Narita H, Kaburaki M, Yabana H, Doi H, Itogawa E, Okamoto M.
    Jpn J Pharmacol; 1996 Dec 10; 72(4):325-33. PubMed ID: 9015741
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Celiprolol augments the effect of physical exercise on insulin sensitivity and serum lipid levels in chronic heart failure.
    Pietilä M, Malminiemi K, Huupponen R, Rouru J, Pulkki K, Pere E, Voipio-Pulkki LM.
    Eur J Heart Fail; 2000 Mar 10; 2(1):81-90. PubMed ID: 10742707
    [Abstract] [Full Text] [Related]

  • 31. Effect of beta-blockade on baroreceptor and autonomic function in heart failure.
    Sanderson JE, Yeung LY, Chan S, Tomlinson B, Kay R, Woo KS, Bernardi L.
    Clin Sci (Lond); 1999 Feb 10; 96(2):137-46. PubMed ID: 9918893
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM, DeLeonardis VM, Hintze TH.
    Br J Pharmacol; 1988 Mar 10; 93(3):501-8. PubMed ID: 2897217
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure.
    Mori T, Hayashi T, Sohmiya K, Okuda N, Shimomura H, Ohkita M, Matsumura Y, Yoshiyama M, Yoshikawa J, Kitaura Y.
    Circ J; 2005 May 10; 69(5):596-602. PubMed ID: 15849448
    [Abstract] [Full Text] [Related]

  • 35. Diminished tolerance of prehypertrophic, cardiomyopathic Syrian hamster hearts to Ca2+ stresses.
    Hano O, Lakatta EG.
    Circ Res; 1991 Jul 10; 69(1):123-33. PubMed ID: 1711422
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
    Ryoke T, Gu Y, Mao L, Hongo M, Clark RG, Peterson KL, Ross J.
    Circulation; 1999 Oct 19; 100(16):1734-43. PubMed ID: 10525494
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.